Sethu Sankaranarayanan

2.7k total citations
38 papers, 1.4k citations indexed

About

Sethu Sankaranarayanan is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sethu Sankaranarayanan has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 17 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sethu Sankaranarayanan's work include Alzheimer's disease research and treatments (18 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Dementia and Cognitive Impairment Research (6 papers). Sethu Sankaranarayanan is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Dementia and Cognitive Impairment Research (6 papers). Sethu Sankaranarayanan collaborates with scholars based in United States, United Kingdom and Sweden. Sethu Sankaranarayanan's co-authors include Ted Yednock, Adam J. Simon, Guoxin Wu, Kaj Blennow, Henrik Zetterberg, Michael K. Ahlijanian, Jere E. Meredith, Charles F. Albright, Valerie Guss and Haiyan Qiu and has published in prestigious journals such as Science, Neuron and Journal of Neuroscience.

In The Last Decade

Sethu Sankaranarayanan

36 papers receiving 1.4k citations

Peers

Sethu Sankaranarayanan
Caroline Van Cauwenberghe Belgium
Kristin R. Wildsmith United States
Brandy Wilkinson United States
Mary Lou Previti United States
Frédérique Bard United States
Yasushi Tomidokoro Japan
Amita Quadros United States
Jose F. Abisambra United States
Jasmina B. Mačkić United States
Grace Gordon United States
Caroline Van Cauwenberghe Belgium
Sethu Sankaranarayanan
Citations per year, relative to Sethu Sankaranarayanan Sethu Sankaranarayanan (= 1×) peers Caroline Van Cauwenberghe

Countries citing papers authored by Sethu Sankaranarayanan

Since Specialization
Citations

This map shows the geographic impact of Sethu Sankaranarayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sethu Sankaranarayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sethu Sankaranarayanan more than expected).

Fields of papers citing papers by Sethu Sankaranarayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sethu Sankaranarayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sethu Sankaranarayanan. The network helps show where Sethu Sankaranarayanan may publish in the future.

Co-authorship network of co-authors of Sethu Sankaranarayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Sethu Sankaranarayanan. A scholar is included among the top collaborators of Sethu Sankaranarayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sethu Sankaranarayanan. Sethu Sankaranarayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lerche, Stefanie, Isabel Wurster, Enza Maria Valente, et al.. (2024). CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants. npj Parkinson s Disease. 10(1). 198–198.
2.
Grover, Anita, Sethu Sankaranarayanan, Vidhu Mathur, et al.. (2023). Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates. Investigative Ophthalmology & Visual Science. 64(2). 3–3. 8 indexed citations
3.
Sun, Yang, David Wirta, Vidhu Mathur, et al.. (2023). Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease. SHILAP Revista de lepidopterología. 3(2). 100290–100290. 16 indexed citations
4.
Andrews‐Zwilling, Yaisa, et al.. (2022). Inhibiting C1q Improves Compound Muscle Action Potential and Reduces Neuronal Damage in the SOD1G93A Mouse Model (P1-13.004). Neurology. 98(18_supplement). 2 indexed citations
5.
Holden, Stephanie S., Fiorella C. Grandi, Bryan Higashikubo, et al.. (2021). Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury. Science. 373(6560). eabj2685–eabj2685. 73 indexed citations
6.
Grover, Anita, Sethu Sankaranarayanan, Vidhu Mathur, et al.. (2021). Pharmacokinetics and target engagement of intravitreal administration of ANX007, an anti-C1q antibody fragment, in nonhuman primates. Investigative Ophthalmology & Visual Science. 62(8). 219–219. 2 indexed citations
7.
Delestrée, Nicolas, Emily V. Fletcher, John G. Pagiazitis, et al.. (2019). The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA. Cell Reports. 29(10). 3087–3100.e7. 86 indexed citations
8.
McGonigal, Rhona, Denggao Yao, Jennifer A. Barrie, et al.. (2016). C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy. Acta Neuropathologica Communications. 4(1). 23–23. 49 indexed citations
9.
Thakker, Deepak R., Sethu Sankaranarayanan, Marcy R. Weatherspoon, et al.. (2015). Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice. Journal of Neuroscience. 35(17). 6931–6936. 26 indexed citations
10.
Wes, Paul D., Amy Easton, John Corradi, et al.. (2014). Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease. PLoS ONE. 9(8). e106050–e106050. 84 indexed citations
11.
Meredith, Jere E., Sethu Sankaranarayanan, Valerie Guss, et al.. (2013). Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease. PLoS ONE. 8(10). e76523–e76523. 152 indexed citations
12.
Sankaranarayanan, Sethu, Dick Terwel, Nina Hoque, et al.. (2013). Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease. Psychopharmacology. 230(2). 279–289. 30 indexed citations
13.
Wu, Guoxin, Sethu Sankaranarayanan, Donna L. Montgomery, et al.. (2011). Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase product. Protein & Cell. 2(7). 573–584. 3 indexed citations
14.
Wu, Guoxin, et al.. (2011). Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Journal of Neuroscience Research. 89(6). 822–832. 26 indexed citations
15.
Toyn, Jeremy H., Mark Thompson, Valerie Guss, et al.. (2010). Viable mouse gene ablations that robustly alter brain Aβ levels are rare. BMC Neuroscience. 11(1). 143–143. 8 indexed citations
16.
Zetterberg, Henrik, Ulf Andréasson, Oskar Hansson, et al.. (2008). Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease. Archives of Neurology. 65(8). 1102–7. 182 indexed citations
17.
Sankaranarayanan, Sethu, Eric A. Price, Guoxin Wu, et al.. (2007). In Vivo β-Secretase 1 Inhibition Leads to Brain Aβ Lowering and Increased α-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1. Journal of Pharmacology and Experimental Therapeutics. 324(3). 957–969. 83 indexed citations
18.
Moore, Keith P., Hong Zhu, Hemaka A. Rajapakse, et al.. (2007). Strategies toward improving the brain penetration of macrocyclic tertiary carbinamine BACE-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5831–5835. 29 indexed citations
19.
Sankaranarayanan, Sethu. (2006). Genetically Modified Mice Models for Alzheimers Disease. Current Topics in Medicinal Chemistry. 6(6). 609–627. 9 indexed citations
20.
Brandish, Philip E., Daniel Holder, Paul Hodor, et al.. (2005). Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex. Neuron. 45(6). 861–872. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Van Cauwenberghe Breakdown of academic impact, for papers by Kristin R. Wildsmith Breakdown of academic impact, for papers by Brandy Wilkinson Breakdown of academic impact, for papers by Mary Lou Previti Breakdown of academic impact, for papers by Frédérique Bard Breakdown of academic impact, for papers by Yasushi Tomidokoro Breakdown of academic impact, for papers by Amita Quadros Breakdown of academic impact, for papers by Jose F. Abisambra Breakdown of academic impact, for papers by Jasmina B. Mačkić Breakdown of academic impact, for papers by Grace Gordon
Rankless by CCL
2026